- Final Results of the Telaprevir Access Program: FibroScan Values Predict Safety and Efficacy in Hepatitis C Patients with Advanced Fibrosis or Cirrhosis2015 | First Faculty of Medicine
- Transient Elastography as the First-Line Assessment of Liver Fibrosis and Its Correlation with Serum Markers2023 | Third Faculty of Medicine, Faculty of Physical Education and Sport, Central Library of Charles University
- The differences in selected biochemical markers and histological findings after bile duct ligation in male and female rats2001 | Faculty of Medicine in Hradec Králové
- Use of Non-Invasive Parameters of Non-Alcoholic Steatohepatitis and Liver Fibrosis in Daily Practice - An Exploratory Case-Control Study2014 | First Faculty of Medicine
- Entecavir for the treatment of chronic hepatitis B infection2013 | Faculty of Medicine in Pilsen
- Factors to Consider in Development of Drugs for Pediatric Nonalcoholic Fatty Liver Disease2019 | First Faculty of Medicine
- A comparison of cost-effectiveness analysis of two strategies - immediate and delayed initiation of treatment of hepatitis C in the Czech Republic2018 | First Faculty of Medicine
- Non-alcoholic fatty liver disease in cohort of patients undergoing bariatric surgery in Military University Hospital Prague2019 | First Faculty of Medicine
- New therapeutic options for HCV in Central Europe2016 | First Faculty of Medicine
- Non-alcoholic liver diseases in steatosis2019 | First Faculty of Medicine
- Unique Biomarkers of Collagen Type III Remodeling Reflect Different Information Regarding Pathological Kidney Tissue Alterations in Patients with IgA Nephropathy2023 | First Faculty of Medicine
- Approach to patients with liver diseases2015 | First Faculty of Medicine
- Predictors of Significant Liver Fibrosis in People with Chronic Hepatitis C Who Inject Drugs in the Czech Republic2023 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Physical Education and Sport, Central Library of Charles University
- Late-Onset Wilson's Disease2007 | First Faculty of Medicine
- Safety and on-treatment efficacy of telaprevir: the early access programme for patients with advanced hepatitis C2014 | First Faculty of Medicine
- A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASHPublication without faculty affiliation
- Challenging management of severe chronic disorders in acute pandemic situation: Chronic liver disease under COVID-19 pandemic as the proof-of-principle model to orchestrate the measures in 3PM context2021 | Third Faculty of Medicine